Olema Pharmaceuticals Inc (OLMA)

10:23 AM

Using flow based indicators on Olema Pharmaceuticals Inc.Earnings Recap Report & Technical Analysis for Trade Confirmation - newser.com

10:23 AM

08:36 AM

Institutional scanner results for Olema Pharmaceuticals Inc.July 2025 PostEarnings & AI Based Buy/Sell Signal Reports - newser.com

08:36 AM

05:25 AM

Leading vs lagging indicators on Olema Pharmaceuticals Inc. performanceStop Loss & Verified Stock Trade Ideas - newser.com

05:25 AM

02:04 AM

How sustainable is Olema Pharmaceuticals Inc. stock dividend payoutJuly 2025 Levels & Low Drawdown Momentum Ideas - newser.com

02:04 AM

Oct 12, 2025

Why Olema Pharmaceuticals Inc. stock attracts global investorsWeekly Earnings Recap & Fast Exit/Entry Strategy Plans - newser.com

Oct 12, 2025

Oct 11, 2025

Olema Pharmaceuticals (NASDAQ:OLMA) Trading Up 5.7%What's Next? - MarketBeat

Oct 11, 2025

Oct 10, 2025

Visual trend scoring systems applied to Olema Pharmaceuticals Inc.2025 Major Catalysts & Fast Exit and Entry Strategy Plans - newser.com

Oct 10, 2025

Oct 10, 2025

Weiss Ratings Reiterates Sell (D-) Rating for Olema Pharmaceuticals (NASDAQ:OLMA) - MarketBeat

Oct 10, 2025

Oct 10, 2025

Can momentum traders help lift Olema Pharmaceuticals Inc.2025 Performance Recap & Fast Momentum Entry Tips - newser.com

Oct 10, 2025

Oct 10, 2025

Guggenheim Begins Coverage on Olema Pharmaceuticals (NASDAQ:OLMA) - Defense World

Oct 10, 2025

Oct 10, 2025

Does Olema Pharmaceuticals Inc. fit your quant trading modelEarnings Risk Summary & Risk Controlled Swing Trade Alerts - newser.com

Oct 10, 2025

Oct 09, 2025

Is now a turning point for Olema Pharmaceuticals Inc.2025 Growth vs Value & Consistent Income Trade Recommendations - newser.com

Oct 09, 2025

Oct 09, 2025

Will Olema Pharmaceuticals Inc. benefit from macro trendsMarket Growth Review & Fast Exit and Entry Trade Guides - newser.com

Oct 09, 2025

Oct 09, 2025

Farther Finance Advisors LLC Grows Stock Holdings in Olema Pharmaceuticals, Inc. $OLMA - Defense World

Oct 09, 2025

Oct 08, 2025

Guggenheim Initiates Coverage on OLMA with a 'Buy' Rating and $2 - GuruFocus

Oct 08, 2025

Oct 08, 2025

Olema Pharmaceuticals (NASDAQ:OLMA) Earns Buy Rating from Analysts at Guggenheim - MarketBeat

Oct 08, 2025

Oct 07, 2025

Brokerages Set Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Target Price at $24.00 - Defense World

Oct 07, 2025

Oct 07, 2025

What analysts say about Olema Pharmaceuticals Inc stockAnalyst Upgrades & Low Cost Portfolio Ideas - earlytimes.in

Oct 07, 2025

Oct 06, 2025

How moving averages guide Olema Pharmaceuticals Inc. tradingStop Loss & Stock Portfolio Risk Control - newser.com

Oct 06, 2025

Oct 06, 2025

How analysts rate Olema Pharmaceuticals Inc. stock todayEarnings Growth Report & Expert Verified Movement Alerts - newser.com

Oct 06, 2025

Oct 05, 2025

Will Olema Pharmaceuticals Inc. stock deliver better than expected guidanceQuarterly Profit Review & Step-by-Step Swing Trade Plans - newser.com

Oct 05, 2025

Oct 05, 2025

How to forecast Olema Pharmaceuticals Inc. trends using time seriesJuly 2025 Spike Watch & Weekly Chart Analysis and Trade Guides - newser.com

Oct 05, 2025

Oct 04, 2025

Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat

Oct 04, 2025

Oct 03, 2025

Metastatic HR+/HER2− Breast Cancer Market Positioned For Accelerated Development Through 2034, Delveinsight Finds Novartis, Arvinas, Olema Pharma, Sichuan Baili Pharma, Ana C Garrido-Castro - Menafn.com

Oct 03, 2025

Oct 03, 2025

Metastatic HR+/HER2− Breast Cancer Market Positioned for Accelerated Development Through 2034, DelveInsight Finds | Novartis, Arvinas, Olema Pharma, Sichuan Baili Pharma, Ana C Garrido-Castro - Barchart.com

Oct 03, 2025

Oct 03, 2025

Metastatic HR+/HER2 Breast Cancer Market Positioned - openPR.com

Oct 03, 2025

Oct 03, 2025

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Oct 03, 2025

Oct 02, 2025

Chart based exit strategy for Olema Pharmaceuticals Inc.Watch List & Stepwise Entry and Exit Trade Signals - newser.com

Oct 02, 2025

Oct 02, 2025

Cancer stocks rebound, outpacing broader markets in Q3 2025 - BioWorld MedTech

Oct 02, 2025

Oct 02, 2025

77,000-share award: Olema Pharmaceuticals grants stock options at $11.04 as inducement - Stock Titan

Oct 02, 2025

Oct 02, 2025

Olema Pharmaceuticals (NASDAQ:OLMA) Trading Down 6.3%Time to Sell? - MarketBeat

Oct 02, 2025

Sep 30, 2025

Goldman Sachs Raises Stake in Olema Pharmaceuticals, Inc. (OLMA) - Insider Monkey

Sep 30, 2025

Sep 29, 2025

11 Best Fast Money Stocks to Buy Now - Insider Monkey

Sep 29, 2025